Alec
Koch

Representing a provider and operator of compression infrastructure used in the production and transfer of oil and natural gas in an investigation related to payments potentially made to Mexican cartels designated as foreign terrorist organizations (FTOs).

Representing the audit committee of a global non-clinical global drug development company in an internal investigation related to potential FCPA and disclosure violations.

Representing a Big Four accounting firm in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor.

Representing the CISO of a software development company in a first-of-its-kind SEC enforcement action relating to the company's disclosures concerning cybersecurity.

Represented a provider of life and health insurance in SEC and DOJ investigations related to allegations made by short sellers regarding the company's financial performance and independent agents. The investigations were closed without enforcement action.

Served as the Independent Compliance Consultant for a registered clearing agency in connection with its SEC settlement relating to liquidity arrangements.

Represented a multinational healthcare company in connection with its continuing self-reporting obligations under an FCPA settlement with the DOJ and SEC.

Represented a global manufacturing company in an SEC investigation of potential FCPA violations in South America that was closed without enforcement action.

Representing the Audit Committee of a space infrastructure development company in an independent investigation of accounting and employment allegations raised by a former employee.

Represented a global manufacturing company in an SEC investigation concerning air emissions-related issues that was closed without enforcement action.

Represented an international chemical company in a negotiated resolution of anti-corruption investigations conducted by U.S. and Dutch authorities.

Represented the audit committee of a public biopharmaceutical company in an internal investigation and related government investigations into allegations of accounting fraud and whistleblower retaliation.

Represented a public company provider of services to the healthcare industry in an SEC investigation of earnings-related disclosures that was resolved on favorable terms.

Represented a public pharmaceutical company in an SEC investigation of potential selective disclosures and Reg FD violations that was resolved on favorable terms.

Represented the independent directors of a commercial flooring company in an SEC investigation of earnings-related disclosures.

Represented the independent directors of a public company in connection with an SEC investigation of earnings-related disclosures.

Represented the CEO of a healthcare logistics company in SEC and DOJ investigations of the company's disclosures concerning PPE transactions.

Represented a public electrical utility in an SEC investigation of the utility’s historical bond offerings.

Represented one of the world’s largest banks in a DOJ investigation concerning the origination and sale of residential mortgage-backed securities during the years leading up to the financial crisis.

Represented the audit committee of a public media analytics company in an internal investigation and related government investigations into more than 20 separate allegations of accounting fraud and whistleblower retaliation.

Defended a major U.S. law firm and several of its partners and employees in an SEC investigation concerning the activities of the firm’s former client, an asset manager. The matter was closed without enforcement action.